In the current hospital—based case—control study, we genotyped three polymorphisms (rs13347C/T, rs10836347C/T, rs11821102G/A) in the 3’–UTR of CD44 and analyzed the association between the genetic variations and CRC risk. The gene discussed is CD44; the disease is colorectal carcinoma.